Skip to main content
. Author manuscript; available in PMC: 2020 Mar 1.
Published in final edited form as: Biochim Biophys Acta Mol Cell Res. 2018 Oct 2;1866(3):371–381. doi: 10.1016/j.bbamcr.2018.09.009

Table 1.

PCR Primers

Primer Specificity Primer Sequences
BiP/GRP78, mRNA FP 5′-GCCATGGTTCTCACTAAAATGAAAGAAAC-3′
RP 5′-TTGGGCATCATTAAAATAGGCTGGTAC-3′
GAPDH, mRNA FP 5′-TTGGTATCGTGGAAGGACTC-3′
RP 5′-ACAGTCTTCTGGGTGGCAGT-3′
EGR1, mRNA FP 5′-AGAAGGACAAGAAAGCAGACAAAAGTGT-3′
RP 5′-GGGGACGGGTAGGAAGAGAG-3′
EGR1, hnRNA FP 5′-CTACGAGCACCTGACCGCAGG-3′
RP 5′-ACAGGACGCCAGGATGGTGG-3′
K-RAS, mRNA FP 5′-CTAGAACAGTAGACACAAAACAGG-3′
RP 5′-CGAACTAATGTATAGAAGGCATC-3′
H-RAS, mRNA FP 5′-TACGGCATCCCCTACATCGAGAC-3′
RP 5′-CACCAACGTGTAGAAGGCATCCTC-3′
N-RAS, mRNA FP 5′-GAGTTACGGGATTCCATTCATTGAAAC-3′
RP 5′-TGGCGTATTTCTCTTACCAGTGTGTAAAA-3′
RAF1, mRNA FP 5′-TATTGGGAAATAGAAGCCAGTGAAGTGA-3′
RP 5′-AACATCTCCGTGCCATTTACCCTTATA-3′
ELK1, mRNA FP 5′-CTGACCCCATCCCTGCTTCCTA-3′
RP 5′-GAAGTGAATGCTAGGAGGCAGCG-3′
SRF, mRNA FP 5′-AGTGGGGAGACCAAGGACACAC-3′
FP 5′-TGGTGGTAGAGGTGCTAGGTGC-3′
SRC, mRNA FP 5′-AGCGGCTCCAGATTGTCAACAA-3′
RP 5′-GGATGTAGCCTGTCTGTCCTGTGC-3′
JNK1, mRNA FP 5′-CCATTTCAGAATCAGACTCATGCCA-3′
RP 5′-TGTGGTGTGAAAACATTCAAAAGGC-3′
JNK2, mRNA FP 5′-GGGATTGTTGTGCTGCATTTGATAC-3′
RP 5′-TGGTTCTGAAAAGGACGGCTTAGTTT-3′
ERK1, mRNA FP 5′-CGCTTCCGCCATGAGAATGTC-3′
RP 5′-CAGGTCAGTCTCCATCAGGTCCTG-3′
ERK2, mRNA FP 5′-CGTGTTGCAGATCCAGACCATGAT-3′
RP 5′-TGGACTTGGTGTAGCCCTTGGAA-3′
hEGR1 P1, ChIP Assay FP 5′-CCCCGTCTCAGAAAGAATAAAAACATTA-3′
RP 5′-CCTTGTGTCTGAATGTCCATTTTGC-3′
hEGR1 P2, ChIP Assay FP 5′-CCTCTTTCGGATTCCCGCAG-3′
RP 5′-GGTCCTTGTGGTGAGGGGTCA-3′
hEGR1 P3, ChIP Assay FP 5′-GAGGGAGCGAGGGAGCAACC-3′
RP 5′-CTCCAAATAAGGTGCTGCCCAAA-3′
hEGR1 P4, ChIP Assay FP 5′-CATATTAGGGCTTCCTGCTTCCCATA-3′
RP 5′-CCGCCTCTATTTGAAGGGTCTGG-3′
hEGR1 P5, ChIP Assay FP 5′-CGCAGAGGACCGAGCTTTTGT-3′
RP 5′-GCAGCCCCGCTCATCAAAA-3′
hEGR1 P6, ChIP Assay FP 5′-GGGGATTCTCCGTATTTGCGTC-3′
RP 5′-GGCTACCATTGACTCCCGAGGT-3′
hEGR1 P7, ChIP Assay FP 5′-GTCCCAGCTCATCAAACCCAGC-3′
RP 5′-AGAAGCGGCGATCACAGGACTC-3′